Emory Behavioral Immunology Program

We study interactions between the brain and the immune system, especially as they relate to the effects of inflammation on the development of psychiatric disorders including depression, anxiety disorders and schizophrenia. We also study the impact of inflammation on the brain in medically ill patients including patients with cancer. Special emphasis in our studies is placed on the effects of inflammation on neurotransmitter systems involving dopamine and glutamate as well as the integrity of local and regional brain networks. Finally, we are exploring a variety of treatment strategies that target the immune system to treat psychiatric disorders. By combining multiple frames of reference, we believe that novel approaches to human suffering can be achieved through strategies that address both brain and immune aspects of health and illness.

In The News

The Need for Speed

New evidence from Dr. Goldsmith's lab suggests that individuals with schizophrenia or schizoaffective disorder have slower outcomes on psychomotor tasks. Read more at Psychiatric Times.

In The News

High Levels of Inflammation and Blood Glucose May Contribute to Anhedonia in MDD

A new paper from our group examines the combined presence of high blood glucose and low tyrosine metabolism in people with Major Depressive Disorder.

In The News

Can anti-inflammatory strategies light up the dim depression pipeline?

Several institutions and organizations including our own are advancing the research of anti-inflammatory drugs as treatment methods for depression and depressive symptoms. Read about it at Nature.

In The News

Microglia: a new target in the brain for depression, Alzheimer’s, and more?

Neuroinflammation is rapidly being tied to a number of physical and cognitive health issues, presenting a new direction for potential treatments.

In The News

Inflammation is Aging your Brain

Dr. Miller spoke with Dave Asprey on his Podcast, Bulletproof radio, to discuss inflammation's effects on aging. Listen to it here.

In The News

Science Says This Is How Stress Kills Your Motivation

How can you maintain your motivation during stressful times? Our research provides one answer. See more at Inc.

In The News

Does Chronic Inflammation Reduce Motivation?

Christopher Bergland takes a look at our research on inflammation and motivation at Psychology Today.

In The News

How Chronic Inflammation May Drive Down Dopamine and Motivation

Computational modeling provides a new look at chronic, low grade inflammation's effects on motivation. Read more at Medical Express.

Emory Behavioral Immunology ProgramFollow

Carmine M. Pariante @ParianteLab·

8 May

We now have the third confirmed speaker for the Presidential Symposium on the first day of the 2021 online @ispne Conference, September 7-9 2021: Jennifer Felger from @BIEmory! The conference is free for member - so go to the society website to register! http://www.ispne.net/

Reply on Twitter 1391061221240152070 Retweet on Twitter 13910612212401520705 Like on Twitter 139106122124015207013

Emory Behavioral Immunology Program @BIEmory·

21 Sep

After many years, we have finally received the green light to conduct this exciting study. Check it out...https://inmunebio.com/index.php/en/news-2/2020/417-muneioncwarded29illionmallusinessn20200916 #depression

Reply on Twitter 1307838319066316800 Retweet on Twitter 1307838319066316800 Like on Twitter 130783831906631680014

Emory Behavioral Immunology Program @BIEmory·

28 Jul

Anhedonia in depressed patients with high inflammation exhibit alterations in glucose metabolism including the energy inefficient glycolysis, Is anhedonia an adaptation to the energy demands of inflammation? Check out https://authors.elsevier.com/c/1bTuQ3AAzzTAEq.

Reply on Twitter 1288109185494732800 Retweet on Twitter 12881091854947328002 Like on Twitter 12881091854947328007